Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis
2019
Background
This study aimed to explore the molecular mechanism and clinical relevance of iguratimod in the regulation of human B cell terminal differentiation.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
67
References
18
Citations
NaN
KQI